Order form for Lenalidomide for pharmacies
+

Giapreza

Stelopharm GmbH

Ihr zuverlässiger Partner
für die Distribution von
pharmazeutischen Produkten

Stelopharm GmbH

your reliable partner for the distribution
of pharmaceutical products

The following content is intended for medical professionals only.

Giapreza®

2.5 mg/ml concentrate for solution for infusion

Manufactured in Europe

INDICATIONS1

 

  • Each ml of concentrate contains angiotensin II acetate aquivalent to 2,5 mg antigiotensin II
  • One vial of 1ml concentrate for solution for infusion contains 2,5 mg of angiotensin II

For the full list of excipients, see section 6.1 of the product information 05/2024

Giapreza_Website-400x400Px


Method of administration:

Giapreza is indicated for the treatment of refractory hypotension in adults with septic or other distributive shock who remain hypotensive despite adequate volume restitution and application of catecholamines and other available vasopressor therapies, see section 5.1 of the product Information 05/2024.



1Giapreza® Summary of Product Characteristics, as of 05/2024

You can find the product information on the website of the European Medicines Agency here.